Acute Administration of Acyl, but Not Desacyl Ghrelin, Decreases Blood Pressure in Healthy Humans
Overview
Authors
Affiliations
Objective: To compare the effects of acyl ghrelin (AG) and desacyl ghrelin (DAG) on blood pressure (BP), heart rate (HR) and other autonomic parameters in healthy humans and to elucidate the hormonal mechanisms through which AG could exert its cardiovascular effects.
Design: Seventeen healthy participants underwent frequent monitoring of systolic (sBP) and diastolic blood pressure (dBP), HR, respiratory rate (RR) and body surface temperature (Temp) during continuous infusion of AG, DAG, combined AG + DAG or saline control before and during an IV glucose tolerance test on 4 separate days. Plasma catecholamines, renin and aldosterone levels were also measured. Differences in outcome measures between treatment groups were assessed using mixed-model analysis.
Results: Compared to the saline control, AG and combined AG + DAG infusions decreased sBP, dBP, mean arterial blood pressure (MAP), HR and Temp. In contrast, DAG infusion did not alter BP, RR or Temp, but did decrease HR. The AG and AG + DAG infusions also raised plasma aldosterone levels compared to saline (P < 0.001) without affecting renin or catecholamine levels.
Conclusions: The decrease in BP, HR, RR and Temp with AG infusion suggests mediation through the autonomic nervous system. The lack of response to DAG suggests that these autonomic effects require activation of the ghrelin receptor.
Cardiovascular autonomic dysfunction and sleep abnormalities in children with Prader-Willi syndrome.
Debs R, Diene G, Cortadellas J, Molinas C, Kermorgant M, Tauber M Clin Auton Res. 2024; .
PMID: 39633031 DOI: 10.1007/s10286-024-01083-8.
Ghrelin is essential for lowering blood pressure during torpor.
Matsui K, Ida T, Oishi K, Kojima M, Sato T Front Endocrinol (Lausanne). 2024; 15:1487028.
PMID: 39449746 PMC: 11499174. DOI: 10.3389/fendo.2024.1487028.
Hedback N, Dichman M, Hindso M, Dirksen C, Jorgensen N, Bojsen-Moller K Am J Physiol Endocrinol Metab. 2024; 327(3):E396-E410.
PMID: 39082900 PMC: 11427089. DOI: 10.1152/ajpendo.00177.2024.
Diverse and Complementary Effects of Ghrelin and Obestatin.
Villarreal D, Pradhan G, Zhou Y, Xue B, Sun Y Biomolecules. 2022; 12(4).
PMID: 35454106 PMC: 9028691. DOI: 10.3390/biom12040517.
Balikcioglu P, Ramaker M, Mason K, Huffman K, Johnson J, Ilkayeva O Front Cardiovasc Med. 2021; 8:721354.
PMID: 34485418 PMC: 8416443. DOI: 10.3389/fcvm.2021.721354.